Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors.
Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors.
复制标题
DOI:
10.3389/fmicb.2021.692423
复制
发表时间:
2021
影响因子:
5.2
通讯作者:
Breitinger HG
中科院分区:
文献类型:
--
作者:
Breitinger U;Ali NKM;Sticht H;Breitinger HG
Severe acute respiratory syndrome coronavirus (SARS-CoV), an enveloped single-stranded positive-sense RNA virus, is a member of the genus Betacoronavirus, family Coronaviridae. The SARS-CoV envelope protein E is a small (∼8.4 kDa) channel-forming membrane protein whose sequence is highly conserved between SARS-CoV and SARS-CoV-2. As a viroporin, it is involved in various aspects of the virus life cycle including assembly, budding, envelope formation, virus release, and inflammasome activation. Here, SARS-CoV E protein was recombinantly expressed in HEK293 cells and channel activity and the effects of viroporin inhibitors studied using patch-clamp electrophysiology and a cell viability assay. We introduced a membrane-directing signal peptide to ensure transfer of recombinant E protein to the plasma membrane. E protein expression induced transmembrane currents that were blocked by various inhibitors. In an ion-reduced buffer system, currents were proton-dependent and blocked by viroporin inhibitors rimantadine and amantadine. I-V relationships of recombinant E protein were not pH-dependent in a classical buffer system with high extracellular Na+ and high intracellular K+. E-protein mediated currents were inhibited by amantadine and rimantadine, as well as 5-(N,N-hexamethylene)amiloride (HMA). We tested a total of 10 flavonoids, finding inhibitory activity of varying potency. Epigallocatechin and quercetin were most effective, with IC50 values of 1.5 ± 0.1 and 3.7 ± 0.2 nM, respectively, similar to the potency of rimantadine (IC50 = 1.7 ± 0.6 nM). Patch-clamp results were independently verified using a modified cell viability assay for viroporin inhibitors. These results contribute to the development of novel antiviral drugs that suppress virus activity and proliferation.
登录
查看更多内容
影响因子:
2.9
作者:
Intharathep, Pathumwadee;Laohpongspaisan, Chittima;Hannongbua, Supot
通讯作者:
Hannongbua, Supot
影响因子:
3.6
作者:
Jalily, Pouria H.;Eldstrom, Jodene;Fedida, David
通讯作者:
Fedida, David
影响因子:
2.7
作者:
González JM;Gomez-Puertas P;Cavanagh D;Gorbalenya AE;Enjuanes L
通讯作者:
Enjuanes L
DOI:
10.1073/pnas.0804958105
发表时间:
2008-08-05
影响因子:
11.1
作者:
Jing, Xianghong;Ma, Chunlong;Lamb, Robert A.
通讯作者:
Lamb, Robert A.
影响因子:
5.6
作者:
Arbely E;Khattari Z;Brotons G;Akkawi M;Salditt T;Arkin IT
通讯作者:
Arkin IT